eHealth, Inc. revised earnings guidance for the full year ending December 31, 2023. Total revenue is expected to be in the range of $439 million to $459 million compared to prior guidance of $420 million to $440 million. GAAP net loss is expected to be in the range of $46 million to $26 million compared to prior guidance of $55 million to $35 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.43 USD | -3.89% | -6.75% | -37.55% |
30/05 | EHealth CFO John Stelben to Retire; John Dolan Named Successor | MT |
30/05 | EHealth, Inc. Appoints John Dolan as SVP and Principal Financial and Accounting Officer, Effective August 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.55% | 16Cr | |
-2.01% | 6.12TCr | |
+12.63% | 5.53TCr | |
+6.13% | 2.61TCr | |
+25.65% | 2.54TCr | |
+13.33% | 835.13Cr | |
+30.53% | 675.76Cr | |
-6.19% | 409.21Cr | |
0.00% | 332.28Cr | |
+9.08% | 232.21Cr |
- Stock Market
- Equities
- EHTH Stock
- News eHealth, Inc.
- EHealth, Inc. Revises Earnings Guidance for the Full Year Ending December 31, 2023